- United States - / - Pharma - / - NYSE:PRGO Can Perrigo (PRGO) Cut Jobs Yet Sustain Innovation, Expansion and Its Dividend Commitment? - On March 11, 2026, Perrigo Company plc outlined at the UBS Global Consumer and Retail Conference its plans to focus on core businesses, deepen retailer partnerships and cut about 7% of its global workforce to streamline operations amid a soft market backdrop. - An interesting angle for investors is how Perrigo aims to balance these cost reductions with continued investment in innovation, geographic expansion and a maintained dividend policy while signaling 2027 as a key year for accelerating its plans. - We’ll now examine how Perrigo’s planned 7% global workforce reduction may influence the company’s existing investment narrative and risk profile. This technology could replace computers: discover 25 stocks that are working to make quantum computing a reality. Perrigo Investment Narrative Recap To own Perrigo today, you need to believe its consumer health and infant nutrition portfolio can eventually convert category softness and recent losses into steadier cash generation. The March 11 workforce reduction and renewed focus on core businesses appear aimed at protecting margins ahead of management’s flagged 2027 ramp. This does not fundamentally change the near term catalyst, which remains visible progress on restoring profitability, or the key risk of weak demand and intense competition limiting that turnaround. The most relevant recent announcement alongside the UBS conference comments is Perrigo’s February 19 decision to maintain its quarterly dividend at US$0.29 per share. In the context of ongoing net losses and a guided sales decline in 2026, continuing the dividend underscores management’s confidence in future cash flows, but also heightens the risk if earnings do not improve, since dividend commitments can compete with reinvestment and restructuring needs at a time when the business is